Chen Yuqiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chen Yuqiang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Lisha Zhang
Department of Emergency, Shanghai Punan Hospital of Pudong New District, Shanghai, China
1 shared publicationNiansong Wang
Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, YISHAN 600, Shanghai, China
1 shared publicationQin Xue
Department of Emergency, Shanghai Punan Hospital of Pudong New District, Shanghai, China
1 shared publicationWang Niansong
Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
1 shared publicationWen Jiejun
Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
1 shared publicationXue Qin
Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
1 shared publication
Latest Publications
- Open Access
- 19 August 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (8)
Infection profile and risk factors for mortality in patients with end-stage renal disease attributable to systemic lupus erythematosus: a two-center integrated study
Objective: Renal impairment is a significant complication of systemic lupus erythematosus (SLE). Additionally, infection in patients with end-stage renal disease (ESRD) attributable to SLE is common, and it increases the risk of mortality. This study explored the infection profile and risk factors for mortality in patients with ESRD attributable to SLE. Methods: In this retrospective, observational study of 125 hospitalized patients, demographic, clinical, laboratory, treatment, and prognosis data were retrieved and analyzed. Results: The 125 cases included 98 pulmonary infections (78.4%), 14 urinary infections (11.2%), and 13 intestinal infections (10.4%). Twenty-six patients died within 1 month after enrollment. Univariate Cox regression and Kaplan–Meier analyses revealed several possible indicators potentially influencing patient survival. Furthermore, multivariate Cox regression analysis identified a higher SLE Disease Activity Index-2000 score, recent higher-dose glucocorticoid use, hypertension, and catheter indwelling as risk factors for higher mortality. Conclusions: Infections were common in patients with advanced SLE and ESRD, and several risk factors might increase the risk of mortality. Once infection is identified, empiric antibiotics should be initiated immediately, and subsequent antibiotics should be applied per the results of drug sensitivity testing to clear the infection.
- 19 August 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (8)
Open AccessInfection profile and risk factors for mortality in patients with end-stage renal disease attributable to systemic lupus erythematosus: a two-center integrated study
Objective: Renal impairment is a significant complication of systemic lupus erythematosus (SLE). Additionally, infection in patients with end-stage renal disease (ESRD) attributable to SLE is common, and it increases the risk of mortality. This study explored the infection profile and risk factors for mortality in patients with ESRD attributable to SLE. Methods: In this retrospective, observational study of 125 hospitalized patients, demographic, clinical, laboratory, treatment, and prognosis data were retrieved and analyzed. Results: The 125 cases included 98 pulmonary infections (78.4%), 14 urinary infections (11.2%), and 13 intestinal infections (10.4%). Twenty-six patients died within 1 month after enrollment. Univariate Cox regression and Kaplan–Meier analyses revealed several possible indicators potentially influencing patient survival. Furthermore, multivariate Cox regression analysis identified a higher SLE Disease Activity Index-2000 score, recent higher-dose glucocorticoid use, hypertension, and catheter indwelling as risk factors for higher mortality. Conclusions: Infections were common in patients with advanced SLE and ESRD, and several risk factors might increase the risk of mortality. Once infection is identified, empiric antibiotics should be initiated immediately, and subsequent antibiotics should be applied per the results of drug sensitivity testing to clear the infection.
- Open Access
- 13 March 2022
- Published by Taylor & Francis in Renal Failure
- Vol. 44 (1) , 473-481
Pifithrin-α ameliorates glycerol induced rhabdomyolysis and acute kidney injury by reducing p53 activation
Rhabdomyolysis is a series of symptoms caused by the dissolution of striped muscle, and acute kidney injury (AKI) is a potential complication of severe rhabdomyolysis. The underlying causes of AKI ...
- 13 March 2022
- Published by Taylor & Francis in Renal Failure
- Vol. 44 (1) , 473-481
Open AccessPifithrin-α ameliorates glycerol induced rhabdomyolysis and acute kidney injury by reducing p53 activation
Rhabdomyolysis is a series of symptoms caused by the dissolution of striped muscle, and acute kidney injury (AKI) is a potential complication of severe rhabdomyolysis. The underlying causes of AKI ...